WO2001094587A3 - Extracellular messengers - Google Patents

Extracellular messengers Download PDF

Info

Publication number
WO2001094587A3
WO2001094587A3 PCT/US2001/018476 US0118476W WO0194587A3 WO 2001094587 A3 WO2001094587 A3 WO 2001094587A3 US 0118476 W US0118476 W US 0118476W WO 0194587 A3 WO0194587 A3 WO 0194587A3
Authority
WO
WIPO (PCT)
Prior art keywords
xmes
provides
extracellular messengers
messengers
polynucleotides
Prior art date
Application number
PCT/US2001/018476
Other languages
French (fr)
Other versions
WO2001094587A2 (en
Inventor
Preeti Lal
Henry Yue
Ann He
Danniel B Nguyen
Narinder Walia
Ameena R Gandhi
Yalda Azimzai
Olga Bandman
Y Tom Tang
Yan Lu
Mariah R Baughn
Brendan M Duggan
Sally Lee
April Hafalia
Jennifer L Policky
Original Assignee
Incyte Genomics Inc
Preeti Lal
Henry Yue
Ann He
Danniel B Nguyen
Narinder Walia
Ameena R Gandhi
Yalda Azimzai
Olga Bandman
Y Tom Tang
Yan Lu
Mariah R Baughn
Brendan M Duggan
Sally Lee
April Hafalia
Jennifer L Policky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Preeti Lal, Henry Yue, Ann He, Danniel B Nguyen, Narinder Walia, Ameena R Gandhi, Yalda Azimzai, Olga Bandman, Y Tom Tang, Yan Lu, Mariah R Baughn, Brendan M Duggan, Sally Lee, April Hafalia, Jennifer L Policky filed Critical Incyte Genomics Inc
Priority to JP2002502128A priority Critical patent/JP2004515216A/en
Priority to AU2001266765A priority patent/AU2001266765A1/en
Priority to CA002409342A priority patent/CA2409342A1/en
Priority to US10/297,639 priority patent/US20040018499A1/en
Priority to EP01944342A priority patent/EP1287141A2/en
Publication of WO2001094587A2 publication Critical patent/WO2001094587A2/en
Publication of WO2001094587A3 publication Critical patent/WO2001094587A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

The invention provides human extracellular messengers (XMES) and polynucleotides which identify and encode XMES. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with aberrant expression of XMES.
PCT/US2001/018476 2000-06-06 2001-06-06 Extracellular messengers WO2001094587A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2002502128A JP2004515216A (en) 2000-06-06 2001-06-06 Extracellular messenger
AU2001266765A AU2001266765A1 (en) 2000-06-06 2001-06-06 Extracellular messengers
CA002409342A CA2409342A1 (en) 2000-06-06 2001-06-06 Extracellular messengers
US10/297,639 US20040018499A1 (en) 2001-06-06 2001-06-06 Extracellular messengers
EP01944342A EP1287141A2 (en) 2000-06-06 2001-06-06 Extracellular messengers

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21023300P 2000-06-06 2000-06-06
US60/210,233 2000-06-06
US21346500P 2000-06-23 2000-06-23
US60/213,465 2000-06-23
US24901900P 2000-11-14 2000-11-14
US60/249,019 2000-11-14

Publications (2)

Publication Number Publication Date
WO2001094587A2 WO2001094587A2 (en) 2001-12-13
WO2001094587A3 true WO2001094587A3 (en) 2002-12-27

Family

ID=27395465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/018476 WO2001094587A2 (en) 2000-06-06 2001-06-06 Extracellular messengers

Country Status (5)

Country Link
EP (1) EP1287141A2 (en)
JP (1) JP2004515216A (en)
AU (1) AU2001266765A1 (en)
CA (1) CA2409342A1 (en)
WO (1) WO2001094587A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040010118A1 (en) * 2000-08-16 2004-01-15 Zerhusen Bryan D. Novel proteins and nucleic acids encoding same
KR20060135648A (en) 2003-12-10 2006-12-29 일라이 릴리 앤드 캄파니 Muteins of fibroblast growth factor 21

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039123A2 (en) * 1996-04-18 1997-10-23 Genetics Institute, Inc. Secreted proteins
WO2000036105A1 (en) * 1998-12-18 2000-06-22 Human Genome Sciences, Inc. Prostacyclin-stimulating factor-2
WO2001093983A1 (en) * 2000-06-02 2001-12-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039123A2 (en) * 1996-04-18 1997-10-23 Genetics Institute, Inc. Secreted proteins
WO2000036105A1 (en) * 1998-12-18 2000-06-22 Human Genome Sciences, Inc. Prostacyclin-stimulating factor-2
WO2001093983A1 (en) * 2000-06-02 2001-12-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YAMAUCHI T ET AL: "PURIFICATION AND MOLECULAR CLONING OF PROSTACYCLIN-STIMULATING FACTOR FROM SERUM-FREE CONDITIONED MEDIUM OF HUMAN DIPLOID FIBROBLAST CELLS", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, vol. 303, 1994, pages 591 - 598, XP002945829, ISSN: 0264-6021 *

Also Published As

Publication number Publication date
CA2409342A1 (en) 2001-12-13
EP1287141A2 (en) 2003-03-05
AU2001266765A1 (en) 2001-12-17
JP2004515216A (en) 2004-05-27
WO2001094587A2 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
WO2001098351A3 (en) G-protein coupled receptors
WO2000070049A3 (en) Extracellular signaling molecules
WO2001042288A3 (en) G-protein coupled receptors
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
WO2001098354A3 (en) Human receptors
WO2001098323A3 (en) G-protein coupled receptors
WO2001072836A3 (en) G-protein coupled receptors
WO2002026950A3 (en) Transferases
WO2002034783A3 (en) Transmembrane proteins
WO2001090359A3 (en) G-protein coupled receptors
WO2002026825A3 (en) G-protein coupled receptors
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2001066742A3 (en) G-protein coupled receptors
WO2002063004A3 (en) G-protein coupled receptors
WO2002024924A3 (en) Protein phosphatases
WO2001092527A3 (en) Regulators of apoptosis
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2002026998A3 (en) Hydrolases
WO2001094391A3 (en) Intracellular signaling proteins
WO2003018612A3 (en) Extracellular messengers
WO2001094587A3 (en) Extracellular messengers
WO2002031152A3 (en) Intracellular signaling molecules
WO2002040671A3 (en) Immunoglobulin superfamily proteins
WO2002079448A3 (en) G-protein coupled receptors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2409342

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 502128

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001944342

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2001944342

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10297639

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001944342

Country of ref document: EP